C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-119.61M
↓ 44% below average
Average (6y)
$-83.23M
Historical baseline
Range
High:$-16.39M
Low:$-139.03M
CAGR
+39.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-119.61M | +14.0% |
| 2023 | $-139.03M | -7.3% |
| 2022 | $-129.53M | -57.7% |
| 2021 | $-82.13M | -35.9% |
| 2020 | $-60.45M | -70.5% |
| 2019 | $-35.45M | -116.3% |
| 2018 | $-16.39M | - |